The Challenge
ProcDNA's Solution
Integrated Data Exploration
Leveraged patient-level data (APLD) and NSP data to capture raw market size and share, providing a foundation for accurate market trend projections.
Custom Patient Universe Creation
Developed a relevant mBC patient universe with tailored business rules for BC/HR+/HER2- populations, ensuring accurate insights and market representation.
Advanced Analytics
Analyzed market size, share, and LOT performance, treatment duration (DOT) by regimen, and source of business (SOB), providing deeper insights into therapy adoption and competitive dynamics.
Ad-hoc Analytics
Delivered comprehensive payer-mix and competitive landscape analysis, aligning client strategies with the latest market trends.
Impact
Actionable Insights
Developed a dynamic mBC Market Dashboard, enabling real-time visibility for faster decision-making.
Enhanced Strategy
Empowered the client with precise go-to-market planning and patient adoption forecasting.
Market Leadership
Refined commercial strategies, enhancing competitive advantage in the oncology market.




















































